Diseases, Conditions, Syndromes

AGA releases best practice advice on long-term PPI use

When proton pump inhibitors (PPIs) are appropriately prescribed, their benefits are likely to outweigh their risks, according to an American Gastroenterological Association (AGA) Clinical Practice Update1 published in Gastroenterology, ...

Diseases, Conditions, Syndromes

Proton pump inhibitor use ups pneumonia risk in dementia

(HealthDay)—For patients with dementia, proton pump inhibitor (PPI) use is associated with increased risk of pneumonia, according to a study published online March 21 in the Journal of the American Geriatrics Society.

Diseases, Conditions, Syndromes

Popular heartburn drugs linked to gradual yet 'silent' kidney damage

Taking popular heartburn drugs for prolonged periods has been linked to serious kidney problems, including kidney failure. The sudden onset of kidney problems often serves as a red flag for doctors to discontinue their patients' ...

Oncology & Cancer

ASCO: antibiotics may have negative impact in renal cancer

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC) receiving immune checkpoint inhibitors, treatment with broad-spectrum antibiotics (ATBs) can reduce progression-free survival, according to research presented ...

Diseases, Conditions, Syndromes

No chemopreventive effect seen for H2RAs in barrett's esophagus

(HealthDay)—For patients with Barrett's esophagus (BE), proton pump inhibitor (PPI) but not histamine-2 receptor antagonist (H2RA) use is associated with reduced risk of neoplastic progression, according to research published ...

Diseases, Conditions, Syndromes

Gastric acid suppressants linked to hospitalization

New research has found a link between popular heartburn drugs and an increase in the risk of infectious gastroenteritis—an illness that results in 13.1 million lost days of work in Australia a year.

page 15 from 30